Home > Journals > Minerva Cardioangiologica > Past Issues > Articles online first > Minerva Cardioangiologica 2017 Oct 25

CURRENT ISSUE
 

ARTICLE TOOLS

Publication history
Reprints
Cite this article as

MINERVA CARDIOANGIOLOGICA

A Journal on Heart and Vascular Diseases


Official Journal of the Italian Society of Angiology and Vascular Pathology
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,695


eTOC

 

Minerva Cardioangiologica 2017 Oct 25

DOI: 10.23736/S0026-4725.17.04532-7

Copyright © 2017 EDIZIONI MINERVA MEDICA

language: English

Transcatheter aortic valve implantation (TAVI) in 2017: recent advances and future development

Florian HECKER 1, Mani ARSALAN 1, Won-Keun KIM 1, 2, Thomas WALTHER 1

1 Department of Cardiac Surgery, Kerckhoff Heartcenter, Bad Nauheim, Germany; 2 Department of Cardiology, Kerckhoff Heartcenter, Bad Nauheim, Germany


PDF  


Transcather aortic valve implantation (TAVI) has become a safe and indispensable treatment option for patients with severe symptomatic aortic stenosis (AS) who are at high or prohibitive surgical risk. In the past years, outcomes after TAVI have improved significantly and TAVI has emerged as a qualified alternative to surgical aortic valve replacement (SAVR) in the treatment of intermediate risk patients. Besides optimized patient screening, advanced imaging and increased examiner experience, transcatheter heart valve (THV) design addressed several key issues like vascular complications, pacemaker implantation and paravalvular leakage rates and improved considerably over time. Currently, several trials are investigating the role of TAVI in low surgical risk patients, novel indications and peri-operative management. In this review we give an overview on 1.) current generation TAVI devices, on 2.) recent clinical trial results and guidelines, and on 3.) future trends and novel developments in the field of interventional treatment of AS.


KEY WORDS: Aortic valve stenosis - TAVI - Transcatheter aortic valve implantation - TAVR - Transcatheter valve replacement - Aortic valve surgery - Embolic protection device - Anticoagulation - Aortic valve regurgitation - Future

top of page

Publication History

Article first published online: October 25, 2017
Manuscript accepted: October 24, 2017
Manuscript received: October 5, 2017

Cite this article as

Hecker F, Arsalan M, Kim WK, Walther T. Transcatheter aortic valve implantation (TAVI) in 2017: recent advances and future development. Minerva Cardioangiol 2017 Oct 25. DOI: 10.23736/S0026-4725.17.04532-7

Corresponding author e-mail

t.walther@kerckhoff-klinik.de